-
Nā Kūwaena Lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Akina Amino maoli |Fmoc-N-Me-Trp(Boc)-OH |Helu CAS.:197632-75-0
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Akina Amino maoli |Fmoc-N-Me-Trp(Boc)-OH |CAS:197632-75-0 |C32H32N2O6
-
Nā Kūwaena Lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Fmoc-Trp-OH |CAS No.:35737-15-6 |C26H22N2O4
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Akina Amino maoli |Fmoc-Trp-OH |CAS:35737-15-6 |C26H22N2O4
-
Nā Kūwaena Lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Fmoc-His(Trt)-OH |CAS No.:109425-51-6 |C40H33N3O4
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Akina Amino maoli |Fmoc-His(Trt)-OH |CAS:109425-51-6 |C40H33N3O4
-
Nā Kūwaena Lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Fmoc-Lys(Boc)-OH |Helu CAS.:71989-26-9
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Akina Amino maoli |Fmoc-Lys(Boc)-OH |CAS:71989-26-9 |C26H32N2O6
-
Fmoc-D-Trp(Boc)-OH 163619-04-3
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Immunology |Hoʻopili ʻana i ka peptide |Akina Amino maoli |Fmoc-D-Trp(Boc)-OH |CAS:163619-04-3 |C31H30N2O6
-
Nā Kūwaena Lapaʻau |Na ma'i hanu |Pranlukast Intermediates |3'-Acetylamino-2'-hydroxyacetophenone |CAS No.103205-33-0
ʻOihana hana a hoʻolako i nā biopharmaceutical |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Na lako maka |Na ma'i hanu |Pranlukast Intermediates |3'-Acetylamino-2'-hydroxyacetophenone |CAS:103205-33-0 |C10H11NO3
-
Nā Kūwaena Lapaʻau |ʻO Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYCINE |CAS No.42288-26-6
ʻOihana hana a hoʻolako i nā biopharmaceutical |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Na lako maka |Anticoagulant API |ʻO Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYCINE |CAS:42288-26-6 |C9H8N2O2
-
Nā Kūwaena Lapaʻau |Mea kūʻē ʻo Integrin |Lifitegrast Intermediates |3-Bromo-L-phenylalanine |CAS No.82311-69-1
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā Kūwaena Lapaʻau |Lifitegrast Intermediates |3-Bromo-L-phenylalanine |CAS:82311-69-1 |C9H10BrNO2
-
Nā Kūwaena Lapaʻau |Mea kūʻē ʻo Integrin |Lifitegrast Intermediates |Boc-3-bromo-L-phenylalanine |CAS No.82278-73-7
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā Kūwaena Lapaʻau |Mea kūʻē ʻo Integrin |Lifitegrast Intermediates |Boc-3-bromo-L-phenylalanine |CAS:82278-73-7 |C14H18BrNO4
-
Laʻau Laʻau Lapaʻau a me nā mea waena |Diabetes |(R)-3-Aminopiperidine dihydrochloride |CAS No.334618-23-4
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā Mea Hana Lapaʻau Hoʻoikaika |Diabetes |(R)-3-Aminopiperidine dihydrochloride |CAS:334618-23-4 |C5H14Cl2N2
-
Nā Kūwaena Lapaʻau |(R)-1-Boc-3-Aminopiperidine |Diabetes |CAS:188111-79-7
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Nā Kūwaena Lapaʻau |(R)-1-Boc-3-Aminopiperidine |CAS:188111-79-7 |C10H20N2O2
-
Mea Makana |Nā Kūwaena Lapaʻau |ʻO ka maʻi puʻuwai |Na ma'i |(S)-(-)-Indoline-2-carboxylic acid |CAS No.79815-20-6
ʻOihana hana a hoʻolako i nā biopharmaceutical |Mea Makana |Nā mea hoʻopaneʻe i waena o nā lāʻau lapaʻau |Na ma'i puuwai |Ke Koko Kiekie |(S)-(-)-Indoline-2-carboxylic acid |CAS:79815-20-6 |C9H9NO2